News Detail
New Delhi, 10 June 2024: The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical sector has reported a decline of 48.3 per cent during the fiscal 2023-24, after a 45.5 per cent growth reported in the previous year.
The fourth quarter of FY24 registere......
View Details
Source : Pharmabiz
Foreign Direct Investment
FDI
pharmaceutical sector
growth
greenfield
Foreign Investment Promotion Board
FIPB
Related News
- Critical medicines for cancer, diabetes set to get expensive as govt clears price hike, say sources (27-03-2025)
- DGFT proposes mandatory GST E-Invoices for pharma export benefits (27-03-2025)
- US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome (27-03-2025)
- FDA approves GSK’s 'Blujepa' for uncomplicated UTIs (27-03-2025)
- Bengal drug control publishes helpline to report fake medicines (27-03-2025)
- Misleading ads: SC asks states UTs to set up grievance redressal mechanism (26-03-2025)
- WHO partners with regulators, experts to strengthen safety and access of medical devices (26-03-2025)
- PCI warns of tough action against inspectors who don't follow its guidelines during inspection (26-03-2025)
- Seizure of fake Human Albumin Vials rings alarm bells (26-03-2025)
- Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025)